ID: ALA2425138

Max Phase: Preclinical

Molecular Formula: C38H40ClN5O5S

Molecular Weight: 714.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCC(=O)Nc1ccc(C)c(-n2nc(CCCC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)c4ccccc4Cl)cc3)c2=O)c1

Standard InChI:  InChI=1S/C38H40ClN5O5S/c1-4-6-16-35-41-44(33-24-29(23-18-26(33)3)40-36(45)17-7-5-2)38(47)43(35)25-27-19-21-28(22-20-27)30-12-9-11-15-34(30)50(48,49)42-37(46)31-13-8-10-14-32(31)39/h8-15,18-24H,4-7,16-17,25H2,1-3H3,(H,40,45)(H,42,46)

Standard InChI Key:  RINFMAFDHJWULG-UHFFFAOYSA-N

Associated Targets(non-human)

Angiotensin II type 1a (AT-1a) receptor 1700 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 714.29Molecular Weight (Monoisotopic): 713.2439AlogP: 7.30#Rotatable Bonds: 14
Polar Surface Area: 132.16Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.21CX Basic pKa: CX LogP: 8.90CX LogD: 7.96
Aromatic Rings: 5Heavy Atoms: 50QED Weighted: 0.12Np Likeness Score: -1.40

References

1. Sharma MC, Sharma S, Sharma P, Kumar A, Bhadoriya KS.  (2013)  Comparative QSAR and pharmacophore analysis for a series of 2,4-dihydro-3H-1,2,4-triazol-3-ones derivatives as angiotensin II AT1 receptor antagonists,  [10.1007/s00044-013-0831-x]

Source